{"id":"W2587369397","doi":"10.1186/s12883-017-0799-0","title":"Peginterferon beta-1a improves MRI measures and increases the proportion of patients with no evidence of disease activity in relapsing-remitting multiple sclerosis: 2-year results from the ADVANCE randomized controlled trial","year":2017,"lang":"en","type":"article","venue":"BMC Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University; NeuroRx Research (Canada); Montreal Neurological Institute and Hospital","funders":"Biogen","keywords":"Medicine; Multiple sclerosis; Neurology; Placebo; Magnetic resonance imaging; Randomized controlled trial; Neurochemistry; Internal medicine; Clinical trial; Neurosurgery; Nuclear medicine; Gastroenterology; Surgery; Radiology; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.002416049,0.000203843,0.001237964,0.00008736752,0.0002360292,0.00002739786,0.000283294,0.0000638948,0.000002473194],"category_scores_gemma":[0.06872336,0.00009498301,0.0001755535,0.00008031248,0.001311926,0.0002063568,0.0002474496,0.000327189,5.606083e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001669916,"about_ca_system_score_gemma":0.00013807,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001299528,"about_ca_topic_score_gemma":0.0007706804,"domain_scores_codex":[0.996491,0.001525031,0.0007003373,0.0004454229,0.0005831051,0.0002550771],"domain_scores_gemma":[0.9872901,0.010049,0.001259444,0.0008573091,0.000460749,0.00008333356],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.7615578,0.0002715634,0.2331422,0.00005744094,0.0001054227,9.108604e-7,0.0001521756,0.00001548964,0.003877573,0.000001745961,0.00001175747,0.0008059528],"study_design_scores_gemma":[0.4425108,0.00114213,0.5546444,0.0003751406,0.0001600211,9.348502e-8,0.00001212877,0.0007730236,0.00032683,0.000006486603,0.000003044474,0.00004594626],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9910226,0.000588809,0.0000476523,0.00187005,0.0001372439,0.006254501,0.00005014844,0.00001292752,0.00001603315],"genre_scores_gemma":[0.9985331,0.0006959937,0.0001271081,0.00005998592,0.0001081554,0.000444157,0.000005459479,0.00001625972,0.000009757505],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3215022,"threshold_uncertainty_score":0.9391212,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05709993393135038,"score_gpt":0.2994747352437943,"score_spread":0.2423748013124439,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}